¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
5/13 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2023-05-10
Á¶È¸¼ö
154


¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.

Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2012³â vaccine ¿¡ ÃâÆǵÈ
"Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway" ÀÔ´Ï´Ù.

ÀÌ ³í¹®Àº ginsenoside Rg1, Re °¡ adjuvant ·Î½á ¾î¶² mechanism À¸·Î ÀÛ¿ëÇÏ´Â Áö ¿¬±¸ÇÑ ³í¹®ÀÔ´Ï´Ù. TLR4 KO ¸¶¿ì½º¿Í reporter cell assay µîÀ» ÀÌ¿ëÇÏ¿© Rg1 °ú Re ÀÇ adjuvant activity °¡ TLR4 signaling pathway ¿Í ¿¬°üµÇ¾î ÀÖ´Ù´Â °ÍÀ» ¹àÇû½À´Ï´Ù.  
¿À·¡µÈ ³í¹®À̱â´Â ÇÏÁö¸¸ ginsenoside ¸¦ adjuvant ·Î½á »ç¿ëÇÏ°í ±× mechanism À» ¹àÈù ¸î ¾ÈµÇ´Â ¿¬±¸ Áß ÇϳªÀ̱⠶§¹®¿¡ °ü·Ã ³»¿ë °øºÎ¸¦ À§ÇØ ¼±Á¤ÇÏ¿´½À´Ï´Ù.  

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
±è¼öÁö µå¸²

³í¹®»çÀÌÆ®:Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway - ScienceDirect
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
5/13 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡¹ßÇ¥ÇÒ ³í¹®Àº 2023³â Cell reports ¿¡ ÃâÆÇµÈ "Crosstalk between ILC2s and Th2 cells varies among mouse models" ÀÔ´Ï´Ù. Type 2 inflammation¿¡ °ü¿©ÇÏ´Â ÁÖ¿äÇÑ ¸é¿ª¼¼Æ÷´ÂTh2 / ILC2¶ó°í ¾Ë·ÁÁ®ÀÖ½À´Ï´Ù. Th2¿Í ILC2 ÀÇ ¿ªÇÒÀº À¯»çÇÏÁö..
ÀÌÀü±Û
5/6 ¹ßÇ¥ ³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹ø ÁÖ ¹ßÇ¥ÀÚ µµºóÀÔ´Ï´Ù. À̹ø ¹ßÇ¥ ³í¹®Àº 21³â 8¿ù EMBo Molecular Medicine ¿¡ ÃâÆÇµÈ 'Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming'ÀÔ´Ï´Ù. Ketogenic diet ¿Í immune system À» Á¢¸ñÇÑ immuno-nutritionalstudy, nutritional immun..